Soil bacteria provide a promising E. coli treatment

December 4, 2018, University of Glasgow
Dr N O'Boyle. Credit: University of Glasgow

E. coli, the notorious bug associated with severe food poisoning and usually caught from undercooked meat, is a common concern for anyone cooking over the festive period.

While thoroughly cooking meat and washing vegetables and hands after can prevent E. coli , treatment for the severe stomach bug can be difficult, as antibiotics are known to make the disease worse by releasing a potent toxin into the infected person's gut.

Now, scientists from the University of Glasgow have found a product made by natural soil-living bacteria that can successfully treat E. coli O157 – [one of] the most serious types of the bug – without producing any serious side effects.

The new study, published in Infection and Immunity, found that Aurodox, a compound first discovered in 1973 but found to be poorly active as a true antibiotic, was able to successfully block E. coli O157 infections.

Scotland has one of the highest incidences of E. coli O157 in the world, and almost half of O157 cases in Scotland are in children under 16 years of age.

The Aurodox compound was able to reduce the ability of E. coli O157 to bind to human cells and, unlike traditional antibiotics, did not cause the release of potent toxins. The researchers believe that this compound could be used as a promising future treatment of E. coli O157 infections.

Professor Andrew Roe, Professor of Molecular Microbiology and lead author of the paper, said: "E. coli O157 is a potentially fatal bacteria bug that currently is not recommended for treatment with antibiotics. We were excited to find that Aurodox was able to prevent the E. coli bacteria from binding to and effectively act as a potent disease-blocking compound.

"Our results are encouraging and suggest that this compound could be used as a promising anti-virulence therapy for the treatment of these infections."

E. coli O157 causes diarrhoea, stomach cramps and occasionally fever. Symptoms may last up to 14 days, however the bacteria can still be present for longer than this. Some people who are infected show no symptoms, while others go on to develop very serious complications, which can sometimes be fatal. Young children are at higher risk of E. coli infection and, along with , are at greater risk of serious complications.

The paper, 'Characterisation of the mode of action of Aurodox, a Type III Secretion System inhibitor from Streptomyces goldiniensis' is published in Infection and Immunity.

Explore further: E. coli-tainted romaine lettuce threatens the frail, sick most

More information: Rebecca E McHugh et al. Characterisation of the mode of action of Aurodox, a Type III Secretion System inhibitor from Streptomyces goldiniensis, Infection and Immunity (2018). DOI: 10.1128/IAI.00595-18

Related Stories

E. coli-tainted romaine lettuce threatens the frail, sick most

November 21, 2018
(HealthDay)—U.S. health officials have warned all Americans to stay away from romaine lettuce this holiday season, due to potential contamination with E. coli.

Computers learn to spot deadly bacteria

September 21, 2016
Machine learning can predict strains of bacteria likely to cause food poisoning outbreaks, research has found.

Rare amino acid influences E. coli infection

January 12, 2015
Scientists have discovered how a rare amino-acid in humans influences the behavior of the E.coli bacterium.

Compound in Apples Inhibits E. coli O157:H7

December 16, 2011
A compound that is abundant in apples and strawberries inhibits the highly pathogenic E. coli O157:H7 biofilms while sparing a beneficial strain of E. coli that also forms biofilms in the human gut, according to a paper in ...

Recommended for you

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.